BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17189221)

  • 1. Multiple granulocytic sarcomas in essential thrombocythemia.
    Tanaka Y; Nagai Y; Mori M; Fujita H; Togami K; Kurata M; Matsushita A; Maeda A; Nagai K; Tanaka K; Takahashi T
    Int J Hematol; 2006 Dec; 84(5):413-6. PubMed ID: 17189221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Essential thrombocythemia in transformation to acute leukemia (FAB-M0) as a natural history from myelofibrosis with t(1;7)].
    Hayashi S; Iwama H; Uchida Y; Kawakubo K; Inatomi Y; Nagasu M; Miyazawa K; Ohyashiki JH; Ohyashiki K; Toyama K
    Rinsho Ketsueki; 1997 May; 38(5):445-7. PubMed ID: 9194391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cell leukemia occurring in a patient with thrombocythemia treated with hydroxyurea and busulphan.
    Candoni A; Tiribelli M; Fanin R
    Leuk Lymphoma; 2004 Apr; 45(4):821-4. PubMed ID: 15160964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Essential thrombocythemia in transformation from myelodysplastic syndrome to acute myeloid leukemia with inv(3) after treatment for gastric cancer].
    Horikoshi M; Machida U; Itikawa M; Seo S; Masuda S; Kurokawa M; Ogawa S; Sunaga S; Honda H; Aoki K; Chiba S; Mitani K; Hirai H; Yazaki Y
    Rinsho Ketsueki; 2000 Jan; 41(1):68-71. PubMed ID: 10695403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition of essential thrombocythemia to megakaryoblastic leukemia after long-term therapy with sequential busulfan, pipobroman and hydroxyurea.
    Sironi M; Bertola G; Lodato A; Spinelli M; Sciariada L
    Acta Haematol; 2003; 109(3):161-2. PubMed ID: 12714827
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term remission of non-Hodgkin lymphoma secondary to the treatment for essential thrombocythemia].
    Kubota Y; Waki M
    Rinsho Ketsueki; 2009 Mar; 50(3):197-202. PubMed ID: 19352088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute biphenotypic leukemia arising in a patient with essential thrombocythemia.
    Wong GC; Lee LH
    Am J Hematol; 2006 Aug; 81(8):624-6. PubMed ID: 16823822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Subcutaneous myeloid sarcoma in a patient with essential thrombocythemia that transformed into acute myeloid leukemia].
    Kuroda H; Jomen W; Yoshida M; Usami M; Shimoyama S; Yamada M; Abe T; Sakurai T; Fujii S; Maeda M; Fujita M; Nagashima K; Uemura S; Kanari Y; Kato J
    Gan To Kagaku Ryoho; 2015 Feb; 42(2):215-9. PubMed ID: 25743142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemic transformation with trisomy 8 in essential thrombocythemia: a report of four cases.
    Hirose Y; Masaki Y; Sugai S
    Eur J Haematol; 2002 Feb; 68(2):112-6. PubMed ID: 12061320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential thrombocythemia transformed to acute myelogenous leukemia with t(3;17)(p24; q12), del(5)(q13q34) after treatment with carboquone and hydroxyurea.
    Tabata M; Imagawa S; Tarumoto T; Ohmine K; Hatake K; Miura Y; Ozawa K
    Jpn J Clin Oncol; 2000 Jul; 30(7):310-2. PubMed ID: 11007164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effective azacitidine treatment for myelodysplastic syndrome transformed from essential thrombocythemia].
    Iizuka H; Yoshimi A; Yamamoto G; Masuda A; Nannya Y; Ichikawa M; Yatomi Y; Kurokawa M
    Rinsho Ketsueki; 2013 May; 54(5):468-72. PubMed ID: 23727686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Essential thrombocythemia that transformed to myelofibrosis after three years].
    Akimoto Y; Ishiyama T; Sano M; Ueno H; Nakamaki T; Hino K; Tomoyasu S; Tsuruoka N
    Rinsho Ketsueki; 1992 Apr; 33(4):520-4. PubMed ID: 1602618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system granulocytic sarcoma in a patient with essential thrombocythemia.
    Grande M
    Am J Hematol; 1996 Jan; 51(1):64-7. PubMed ID: 8571939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leg ulcers and hydroxyurea: report of three cases with essential thrombocythemia.
    Demirçay Z; Cömert A; Adigüzel C
    Int J Dermatol; 2002 Dec; 41(12):872-4. PubMed ID: 12492973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Essential thrombocythemia in transformation to smouldering megakaryoblastic leukemia with myelofibrosis].
    Uesugi Y; Toba K; Nikkuni K; Fuse I; Koike T; Shibata A
    Rinsho Ketsueki; 1995 Oct; 36(10):1210-6. PubMed ID: 8531333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment outcome of patients with essential thrombocythemia at our department in Hungary].
    Iványi JL; Marton É; Plander M; Szendrei T
    Orv Hetil; 2016 Feb; 157(9):336-41. PubMed ID: 26895801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythemas associated with essential thrombocythemia.
    Tsuji T
    J Dermatol; 1995 Oct; 22(10):788-94. PubMed ID: 8586763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Essential thrombocythemia transformed to acute myeloblastic leukemia].
    Okuda M; Shishido T; Sato A; Nagai T; Sugawara T; Kameoka J; Kaneda K; Meguro K; Fukuhara O; Sakurai T
    Rinsho Ketsueki; 1990 Oct; 31(10):1689-93. PubMed ID: 2255058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of myelofibrosis that developed polycythemia vera following treatment with ranimustine and then acute myelogenous leukemia (M0)].
    Harashima S; Okamura T; Umeno M; Takaki K
    Rinsho Ketsueki; 1996 Aug; 37(8):713-8. PubMed ID: 8827883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of essential thrombocythemia to blastic crisis via idiopathic myelofibrosis.
    Emilia G; Sacchi S; Temperani P; Longo R; Vecchi A
    Leuk Lymphoma; 1993 Mar; 9(4-5):423-6. PubMed ID: 8348078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.